Download PDF
Klin Monbl Augenheilkd 2012; 229(3): 227-230
DOI: 10.1055/s-0031-1299326
Statement
© Georg Thieme Verlag KG Stuttgart · New York

Stellungnahme der Retinologischen Gesellschaft, der Deutschen Ophthalmologischen Gesellschaft und des Berufsverbands der Augenärzte Deutschlands zur epimakulären Brachytherapie bei altersbedingter Makuladegeneration

Comments of the Retinological Society, the German Ophthalmology Siocietry and the Professional Union of German Ophthalmologists on Epimacular Brachytherapy for Age-Related Macular Degeneration Das Redaktionskomitee ist am Ende des Beitrags genannt.
Further Information

Publication History

06 February 2012

17 February 2012

Publication Date:
02 March 2012 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

altersbedingte Makuladegeneration - Radiotherapie

Key words

age related macular Degeneration - radiation treatment
 

  • Literatur

  • 1 Neue Aspekte in der Therapie der neovaskulären altersabhangigen Makuladegeneration. Aktuelle Stellungnahme der Retinologischen Gesellschaft, der Deutschen Ophthalmologischen Gesellschaft und des Berufsverbands der Augenärzte Deutschlands e. V. (Stand: März 2009). Ophthalmologe 2009; 106: 457-464
    CrossrefPubMedGoogle Scholar
  • 2 Finger PT, Berson A, Ng T et al. Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol 1999; 127: 170-177
    CrossrefPubMedGoogle Scholar
  • 3 Zambarakji HJ, Lane AM, Ezra E et al. Proton beam irradiation for neovascular age-related macular degeneration. Ophthalmology 2006; 113: 2012-2019
    CrossrefPubMedGoogle Scholar
  • 4 Schilling H, Sauerwein W, Lommatzsch A et al. Long-term results after low dose ocular irradiation for choroidal haemangiomas. Br J Ophthalmol 1997; 81: 267-273
    CrossrefPubMedGoogle Scholar
  • 5 Scott TA, Augsburger JJ, Brady LW et al. Low dose ocular irradiation for diffuse choroidal hemangiomas associated with bullous nonrhegmatogenous retinal deta chment. Retina 1991; 11: 389-393
    CrossrefPubMedGoogle Scholar
  • 6 Timke C, Zieher H, Roth A et al. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy. Clin Cancer Res 2008; 14: 2210-2219
    CrossrefPubMedGoogle Scholar
  • 7 Senan S, Smit EF. Design of clinical trials of radiation combined with antiangiogenic therapy. Oncologist 2007; 12: 465-477
    CrossrefPubMedGoogle Scholar
  • 8 Chakravarthy U, Houston RF, Archer DB. Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Ophthalmol 1993; 77: 265-273
    CrossrefPubMedGoogle Scholar
  • 9 Evans JR, Sivagnanavel V, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2010; 5: CD004004
    PubMedGoogle Scholar
  • 10 Hanlon J, Lee C, Chell E et al. Kilovoltage stereotactic radiosurgery for age-related macular degeneration: assessment of optic nerve dose and patient effective dose. Med Phys 2009; 36: 3671-3681
    CrossrefPubMedGoogle Scholar
  • 11 Jaakkola A, Heikkonen J, Tommila P et al. Strontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized study. Ophthalmology 2005; 112: 567-573
    CrossrefPubMedGoogle Scholar
  • 12 Jaakkola A, Heikkonen J, Tommila P et al. Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1998; 236: 24-30
    CrossrefPubMedGoogle Scholar
  • 13 Holmes SM, Micka JA, DeWerd LA. Investigation of a 90Sr/90Y source for intra-ocular treatment of wet age-related macular degeneration. Med Phys 2009; 36: 4370-4378
    CrossrefPubMedGoogle Scholar
  • 14 Hart PM, Chakravarthy U, Mackenzie G et al. Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration. Arch Ophthalmol 2002; 120: 1029-1038
    CrossrefPubMedGoogle Scholar
  • 15 Gertner M, Chell E, Pan KH et al. Stereotactic targeting and dose verification for age-related macular degeneration. Med Phys 2010; 37: 600-606
    CrossrefPubMedGoogle Scholar
  • 16 Moshfeghi DM, Kaiser PK, Gertner M. Stereotactic low-voltage x-ray irradiation for age-related macular degeneration. Br J Ophthalmol 2011; 95: 185-188
    CrossrefPubMedGoogle Scholar
  • 17 Petrarca R, Jackson TL. Radiation therapy for neovascular age-related macular degeneration. Clin Ophthalmol 2011; 5: 57-63
    PubMedGoogle Scholar
  • 18 Finger PT, Gelman YP, Berson AM et al. Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study. Br J Ophthalmol 2003; 87: 1497-1503
    CrossrefPubMedGoogle Scholar
  • 19 Saric B, Sikic J, Katusic D et al. Brachytherapy – optional treatment for choroidal neovascularization secondary to age-related macular degeneration. Coll Antropol 2001; 25 Suppl: 89-96
    PubMedGoogle Scholar
  • 20 Kirwan JF, Constable PH, Murdoch IE et al. Beta irradiation: new uses for an old treatment: a review. Eye 2003; 17: 207-215
    CrossrefPubMedGoogle Scholar
  • 21 Hokkanen J, Heikkonen J, Holmberg P. Theoretical calculations of dose distributions for beta-ray eye applicators. Med Phys 1997; 24: 211-213
    CrossrefPubMedGoogle Scholar
  • 22 Avila MP, Farah ME, Santos A et al. Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration. Br J Ophthalmol 2009; 93: 305-309
    CrossrefPubMedGoogle Scholar
  • 23 Avila MP, Farah ME, Santos A et al. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD. Retina 2009; 29: 157-169
    CrossrefPubMedGoogle Scholar
  • 24 Archer DB, Gardiner TA. Ionizing radiation and the retina. Curr Opin Ophthalmol 1994; 5: 59-65
    PubMedGoogle Scholar
  • 25 Parsons JT, Bova FJ, Fitzgerald CR et al. Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994; 30: 765-773
    CrossrefPubMedGoogle Scholar
  • 26 Gunduz K, Shields CL, Shields JA et al. Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 1999; 117: 609-614
    CrossrefPubMedGoogle Scholar
  • 27 Mauget-Faysse M, Coquard R, Francais-Maury C et al. Radiothérapie dans la dégénérescence maculaire liée a l’age: facteurs de risque de survenue des complications, prévention et traitement des effets secondaires. J Fr Ophtalmol 2000; 23: 127-136
    PubMedGoogle Scholar
  • 28 Kumar B, Palimar P. Accelerated radiation retinopathy in diabetes and pregnancy. Eye 2000; 14 (01) 107-108
    CrossrefPubMedGoogle Scholar
  • 29 Logani S, Cho AS, Ali BH et al. Single-dose compared with fractionated-dose radiation of the OM431 choroidal melanoma cell line. Am J Ophthalmol 1995; 120: 506-510
    PubMedGoogle Scholar
  • 30 Chakravarthy U. Radiotherapy for choroidal neovascularisation of age-related macular degeneration: a fresh perspective. Eye 2000; 14 (02) 151-154
    CrossrefPubMedGoogle Scholar
  • 31 Rizzo S, Belting C, Genovesi-Ebert F et al. Incidence of retinal detachment after small-incision, sutureless pars plana vitrectomy compared with conventional 20-gauge vitrectomy in macular hole and epiretinal membrane surgery. Retina 2010; 30: 1065-1071
    CrossrefPubMedGoogle Scholar
  • 32 Laude A, Tan LE, Wilson CG et al. Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics. Prog Retin Eye Res 2010; 29: 466-475
    CrossrefPubMedGoogle Scholar